Dose Optimization Trial of CD19 Redirected Autologous T Cells

Clinical trial NCT01747486 · COMPLETED

Trial details

NCT number: NCT01747486
Sponsor: University of Pennsylvania
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLL

Start date: 2013-01-02
Primary completion: 2017-12-13
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.